• HOME
  • 교육자료
  • 연구논문/보고서

연구논문/보고서

제목 Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study
내용
Prevalence, Nature, Severity and Preventability of Adverse Drug Events in Mental Health Settings: Findings from the MedicAtion relateD harm in mEntal health hospitals (MADE) Study

Drug Saf. 2021 Aug;44(8):877-888. doi: 10.1007/s40264-021-01088-6. Epub 2021 Jul 5.

Ghadah H Alshehri 1 2, Darren M Ashcroft 3 4, Joanne Nguyen 3 5, Mark Hann 6, Richard Jones 7, Kristof Seaton 8, Graham Newton 9, Richard N Keers 3 5

1Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK. [email protected].
2Pharmacy Practice Department, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. [email protected].
3Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.
4NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
5Pharmacy Department, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
6Division of Population Health, Health Services and Primary Care, The University of Manchester, Manchester, UK.
7Adult Inpatient Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
8Pharmacy Department, Pennine Care NHS Foundation Trust, Ashton-Under-Lyne, UK.
9Pharmacy Department, North West Boroughs Healthcare NHS Foundation Trust, Warrington, UK.

Abstract
Introduction: Adverse drug events (ADEs) constitute a significant problem in hospitals worldwide. However, little is known about their burden in mental health hospitals.
Objective: The objective of this study was to determine the prevalence, nature, severity and preventability of ADEs across three mental health trusts in England.
Methods: Trained clinical pharmacists retrospectively screened randomly sampled medical records to identify ADEs. An expert panel assessed all suspected ADEs to determine their causality, preventability and severity. Multivariable regression analysis (adjusted for clustering between hospitals) examined risk factors associated with ADEs.
Results: In total, 227 patient admissions comprising 10,164 patient-days of follow-up were included in the study. The adjusted rate of confirmed ADEs was 12.6 (95% confidence interval [CI] 5.6-26.0) per 100 admissions and 2.6 (95% CI 1.0-6.9) per 1000 patient-days, with almost a fifth of these ADEs judged as preventable 19.1% (n = 9/47). The majority of ADEs were of at least moderate clinical severity (29/47; 61.7%), and medicines from the central nervous system class were most commonly implicated in ADEs (45/47; 95.7%) including antipsychotics (31/45; 68.8%) and antidepressants (7/45; 15.5%). Patients with a hospital stay of more than 30 days (odds ratio 16.58, 95% CI 3.77-72.85) and patients with a stay of 8-30 days (odds ratio 5.32, 95% CI 1.22-23.07) were more likely to experience an ADE compared with patients with a stay of 1-7 days.
Conclusions: Adverse drug events in National Health Service mental health hospitals pose an important threat to patient safety. Targets for remedial interventions have been suggested for further exploration to improve patient safety in this setting.

초록 (구글 한글 번역)
서론: 약물 부작용(ADE)은 전 세계 병원에서 심각한 문제를 구성한다. 그러나 정신 건강 병원에서의 부담에 대해서는 알려진 바가 거의 없다.
목적: 이 연구의 목적은 영국의 3개 정신 건강 트러스트에서 ADE의 유병률, 특성, 중증도 및 예방 가능성을 결정하는 것이었다.
방법: 훈련된 임상 약사가 ADE를 식별하기 위해 무작위로 샘플링된 의료 기록을 후향적으로 선별했다. 전문가 패널은 모든 의심되는 ADE를 평가하여 인과성, 예방 가능성 및 심각성을 결정했다. 다변수 회귀 분석(병원 간 클러스터링을 위해 조정됨)은 ADE와 관련된 위험 요소를 조사했다.
결과: 10,164 환자-일의 추적 관찰을 포함하는 총 227명의 환자 입원이 연구에 포함되었다. 확인된 ADE의 조정된 비율은 입원 100건당 12.6(95% 신뢰 구간[CI] 5.6-26.0)이고 환자-일 1,000일당 2.6(95% CI 1.0-6.9)이었으며 이러한 ADE의 거의 1/5이 예방 가능한 것으로 판단되었다. 19.1 %(n = 9/47). 대부분의 ADE는 중등도 이상의 임상 중증도(29/47, 61.7%)였으며, 중추신경계 계열의 의약품은 항정신병제(31/45, 68.8), 항우울제(7/45, 15.5%)를 포함한 ADE(45/47, 95.7%)와 가장 일반적으로 관련되었다. 30일 이상 입원한 환자(교차비 16.58, 95% CI 3.77-72.85)와 8-30일 입원 환자(교차비 5.32, 95% CI 1.22-23.07)는 1-7일 입원환자에 비해 ADE를 더 경험할 가능성이 높았다.
결론: 국립 보건원 정신 건강 병원의 약물 위해사건은 환자 안전에 중요한 위협이 된다. 이 환경에서 환자 안전을 개선하기 위한 추가 조사를 위해 교정 중재 대상이 제안되었다.
관련링크 #1 관련링크 https://pubmed.ncbi.nlm.nih.gov/34224091/
태그 #약물위해사건 # 환자안전 # 정신건강